Evidence map›Paper›PMID 33430124›Full record

ArticleMarine drugs2021

Rare Chromone Derivatives from the Marine-Derived

Yi-Cheng Chu, Chun-Hao Chang, Hsiang-Ruei Liao, Ming-Jen Cheng, Ming-Der Wu, Shu-Ling Fu, Jih-Jung Chen

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Chemical Composition, Antioxidant, and Cytotoxic Effects ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yi-Cheng ChuInstitute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.
Chun-Hao ChangInstitute of Biopharmaceutical Sciences, Pharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.
Hsiang-Ruei LiaoGraduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Ming-Jen ChengBioresource Collection and Research Center (BCRC), Food Industry Research and Development Institute (FIRDI), Hsinchu 300, Taiwan.
Ming-Der WuBioresource Collection and Research Center (BCRC), Food Industry Research and Development Institute (FIRDI), Hsinchu 300, Taiwan.
Shu-Ling FuInstitute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0003-2895-225X
Jih-Jung ChenFaculty of Pharmacy, School of Pharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.ORCID 0000-0002-5680-9533
National Yang Ming Chiao Tung University · TWFood Industry Research and Development Institute · TWChang Gung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three new and rare chromone derivatives, epiremisporine C (

Indexed as

A549 CellsAdultAnti-Bacterial AgentsAntibiotics, AntineoplasticAnti-Inflammatory Agents, Non-Steroidalbcl-2-Associated X ProteinCaspase 3Cell Line, TumorChromonesFermentationHumansIn Vitro TechniquesMagnetic Resonance SpectroscopyMicrobial Sensitivity TestsMolecular StructureNeutrophilsAnti-Bacterial AgentsAntibiotics, AntineoplasticAnti-Inflammatory Agents, Non-Steroidalbcl-2-Associated X ProteinCASP3 protein, humanCaspase 3ChromonesProto-Oncogene Proteins c-bcl-2Superoxidesanti-cancer activityanti-inflammatory activitychromone derivativesPenicillium citrinum

Identifiers

PMID33430124
PMCPMC7827422
OpenAlexW3118743839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.